CIK: 0001952142
Total reported value
$522.3M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ROIV | Roivant Sciences Ltd. | Stock-Healthcare | 12.72% | -1.55% | +176.72% | |
| 2 | QURE | uniQure N.V. | Stock-Other | 6.11% | — | -8.81% | |
| 3 | SRRK | Scholar Rock Holding CORP | Stock-Other | 5.42% | +3.08% | +40.99% | |
| 4 | IMVT | Immunovant INC | Stock-Other | 5.14% | — | +31.32% | |
| 5 | DNLI | Denali Therapeutics INC | Stock-Other | 5.05% | — | +145.04% | |
| 6 | SNDX | Syndax Pharmaceuticals INC | Stock-Other | 4.22% | — | -38.20% | |
| 7 | 260 | Centessa Pharmaceuticals-adr | Stock-Other | 3.37% | -4.95% | EXIT | |
| 8 | BHVN | Biohaven Ltd. | Stock-Other | 3.30% | +2.58% | NEW | |
| 9 | WVE | Wave Life Sciences Ltd. | Stock-Other | 3.09% | — | +134.37% | |
| 10 | CDTX | Cidara Therapeutics INC | Stock-Other | 2.92% | — | -42.90% | |
| 11 | ABVX | Abivax Sa-adr | Stock-Other | 2.83% | -2.37% | +89.49% | |
| 12 | IDYA | Ideaya Biosciences INC | Stock-Other | 2.03% | -0.96% | EXIT | |
| 13 | RYTM | Rhythm Pharmaceuticals INC | Stock-Other | 1.85% | -1.08% | EXIT | |
| 14 | ARGX | Argenx Se - Adr | Stock-Healthcare | 1.84% | — | — | |
| 15 | SRZN | Surrozen INC | Stock-Other | 1.84% | — | +3.92% | |
| 16 | RVMD | Revolution Medicines INC | Stock-Healthcare | 1.73% | +4.49% | — | |
| 17 | RZLT | Rezolute INC | Stock-Other | 1.73% | — | +42.34% | |
| 18 | GHRS | GH Research PLC | Stock-Other | 1.56% | — | +440.81% | |
| 19 | ARQT | Arcutis Biotherapeutics INC | Stock-Other | 1.56% | — | +100.27% | |
| 20 | VTGN | Vistagen Therapeutics INC | Stock-Other | 1.55% | — | +3.13% | |
| 21 | XENE | Xenon Pharmaceuticals INC | Stock-Other | 1.55% | -1.11% | — | |
| 22 | ALKS | Alkermes plc | Stock-Healthcare | 1.45% | — | -31.18% | |
| 23 | CELC | Celcuity INC | Stock-Other | 1.35% | -0.71% | — | |
| 24 | BBIO | Bridgebio Pharma INC | Stock-Healthcare | 1.33% | — | +133.27% | |
| 25 | INSM | Insmed INC | Stock-Healthcare | 1.25% | — | -29.49% | |
| 26 | DYN | Dyne Therapeutics INC | Stock-Other | 1.20% | -1.04% | — | |
| 27 | MLYS | Mineralys Therapeutics INC | Stock-Other | 1.20% | +0.97% | -74.97% | |
| 28 | AKRO | Akero Therapeutics INC | Stock-Other | 1.16% | — | +17.24% | |
| 29 | JAZZ | Jazz Pharmaceuticals plc | Stock-Healthcare | 1.03% | — | — | |
| 30 | RNAGBP | Avidity Biosciences INC | Stock-Other | 1.00% | — | — | |
| 31 | NAMS | NewAmsterdam Pharma Company N.V. | Stock-Other | 0.86% | — | -1.36% | |
| 32 | OCUL | Ocular Therapeutix INC | Stock-Other | 0.84% | -1.09% | EXIT | |
| 33 | MDGL | Madrigal Pharmaceuticals INC | Stock-Healthcare | 0.75% | -1.77% | EXIT | |
| 34 | AMLX | Amylyx Pharmaceuticals INC | Stock-Other | 0.75% | — | — | |
| 35 | INCY | Incyte CORP | Stock-Healthcare | 0.74% | -1.04% | EXIT | |
| 36 | GPCR | Structure Therapeutics INC | Stock-Other | 0.73% | -2.34% | — | |
| 37 | TRVI | Trevi Therapeutics INC | Stock-Other | 0.64% | -0.86% | EXIT | |
| 38 | PTGX | Protagonist Therapeutics INC | Stock-Other | 0.64% | — | +185.95% | |
| 39 | NKTR | Nektar Therapeutics | Stock-Other | 0.61% | -1.29% | EXIT | |
| 40 | ASND | Ascendis Pharma A/S | Stock-Other | 0.60% | — | — | |
| 41 | TECX | Tectonic Therapeutic INC | Stock-Other | 0.59% | — | +372.50% | |
| 42 | HROW | Harrow INC | Stock-Other | 0.56% | — | — | |
| 43 | TSHA | Taysha Gene Therapies INC | Stock-Other | 0.55% | — | -30.26% | |
| 44 | EQ | Equillium INC | Stock-Other | 0.55% | — | — | |
| 45 | UTHR | United Therapeutics CORP | Stock-Healthcare | 0.53% | — | — | |
| 46 | CGON | Cg Oncology INC | Stock-Other | 0.51% | +2.66% | NEW | |
| 47 | QQQ | Invesco Qqq Trust Series 1 | ETF-Tech | 0.46% | — | — | |
| 48 | BBOT | Bridgebio Oncology Therapeut | Stock-Other | 0.43% | — | — | |
| 49 | TNGX | Tango Therapeutics INC | Stock-Other | 0.41% | +0.80% | NEW | |
| 50 | ORIC | Oric Pharmaceuticals INC | Stock-Other | 0.40% | — | -17.09% |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ROIV | Roivant Sciences Ltd. | +4.4% | +176.72% | Add |
| 2 | QURE | uniQure N.V. | +3.6% | -8.81% | Trim |
| 3 | WVE | Wave Life Sciences Ltd. | +2.9% | +134.37% | Add |
| 4 | DNLI | Denali Therapeutics INC | +2.2% | +145.04% | Add |
| 5 | IDYA | Ideaya Biosciences INC | +1.7% | +124.15% | Add |
| 6 | BHVN | Biohaven Ltd. | +1.4% | +756.81% | Add |
| 7 | RYTM | Rhythm Pharmaceuticals INC | +1.3% | -48.26% | Add |
| 8 | MLYS | Mineralys Therapeutics INC | +1.2% | -74.97% | Add |
| 9 | SRZN | Surrozen INC | +0.9% | +3.92% | Add |
| 10 | DYN | Dyne Therapeutics INC | +0.9% | — | Add |
| 11 | 260 | Centessa Pharmaceuticals-adr | +0.7% | -34.59% | Add |
| 12 | OCUL | Ocular Therapeutix INC | +0.6% | — | Add |
| 13 | IMVT | Immunovant INC | +0.5% | +31.32% | Add |
| 14 | VTGN | Vistagen Therapeutics INC | -0.1% | +3.13% | Add |
| 15 | SRRK | Scholar Rock Holding CORP | -0.4% | +40.99% | Add |
| 16 | 4XC1 | Kalvista Pharmaceuticals INC | -1.3% | -85.32% | Trim |
| 17 | TARA | Protara Therapeutic INC | -1.3% | -68.20% | Trim |
| 18 | CGON | Cg Oncology INC | -1.8% | — | Trim |
| 19 | RVMD | Revolution Medicines INC | -1.9% | — | Trim |
| 20 | MDGL | Madrigal Pharmaceuticals INC | -3.6% | -84.43% | Trim |
| 21 | ACLXGBX | Arcellx INC | -5.5% | -94.35% | Trim |
| 22 | ✓ | Merus N V | — | EXIT | Sold out |
| 23 | CDTX | Cidara Therapeutics INC | — | NEW | New buy |
| 24 | ABVX | Abivax Sa-adr | — | NEW | New buy |
| 25 | NUVL | Nuvalent Inc-a | — | EXIT | Sold out |
| 26 | JANX | Janux Therapeutics INC | — | EXIT | Sold out |
| 27 | ARGX | Argenx Se - Adr | — | NEW | New buy |
| 28 | RZLT | Rezolute INC | — | NEW | New buy |
| 29 | GHRS | GH Research PLC | — | NEW | New buy |
| 30 | SWTXUSD | Springworks Therapeutics INC | — | EXIT | Sold out |
| 31 | CELC | Celcuity INC | — | NEW | New buy |
| 32 | CYTK | Cytokinetics INC | — | EXIT | Sold out |
| 33 | 2655787D | Blueprint Medicines CORP | — | EXIT | Sold out |
| 34 | JAZZ | Jazz Pharmaceuticals plc | — | NEW | New buy |
| 35 | RNAGBP | Avidity Biosciences INC | — | NEW | New buy |
| 36 | EWTX | Edgewise Therapeutics INC | — | EXIT | Sold out |
| 37 | AMLX | Amylyx Pharmaceuticals INC | — | NEW | New buy |
| 38 | INCY | Incyte CORP | — | NEW | New buy |
| 39 | GPCR | Structure Therapeutics INC | — | NEW | New buy |
| 40 | TRVI | Trevi Therapeutics INC | — | NEW | New buy |
| 41 | NKTR | Nektar Therapeutics | — | NEW | New buy |
| 42 | TECX | Tectonic Therapeutic INC | — | NEW | New buy |
| 43 | HROW | Harrow INC | — | NEW | New buy |
| 44 | TSHA | Taysha Gene Therapies INC | — | NEW | New buy |
| 45 | EQ | Equillium INC | — | NEW | New buy |
| 46 | UTHR | United Therapeutics CORP | — | NEW | New buy |
| 47 | ELVN | Enliven Therapeutics INC | — | EXIT | Sold out |
| 48 | NBIX | Neurocrine Biosciences INC | — | EXIT | Sold out |
| 49 | QQQ | Invesco Qqq Trust Series 1 | — | NEW | New buy |
| 50 | ✓ | Helix Acquisition CORP Ii | — | EXIT | Sold out |